Entries by aaron

Novartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults

Basel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing authorization for Scemblix (asciminib) for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) in all lines of treatment. “For […]

NEET PG Counselling 2025: MCC notifies NMC interim guidelines for PwBD candidates, details

New Delhi: The National Medical Commission (NMC) issued Interim Guidelines on Assessment Method for Granting Admission in Postgraduate Courses to Persons with Benchmark Disabilities (PwBD) for the academic year 2025-26, in accordance with the Rights of Persons with Disabilities (RPwD) Act, 2016, and directives of the Ministry of Social Justice and Empowerment. The guidelines, shared by the […]

JIPMER inaugurates wellness club at Murungapakkam PHC

Puducherry: The Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), in partnership with the Murungapakkam Primary Health Centre (PHC), has inaugurated a Model Wellness Club and an Open Community Fitness Centre within the premises.  This initiative, under the ICMR-funded Community Action for Lifestyle Modification (CALM) Project, supports the Fit India Mission by promoting healthier lifestyle […]

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Bangalore: Strides Pharma Science Limited has announced that one of its step-down wholly owned subsidiary will market the WHO-prequalified generic version of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Africa, strengthening women’s access to affordable, quality reproductive health solutions. Developed by Incepta Pharmaceuticals under the brand Medogen SubQ, and supported by the Children’s Investment Fund Foundation (CIFF) […]

Over 250 additional PG medical seats sanctioned to Gujarat medical colleges

Gujarat: Over 250 additional PG medical seats have been approved in various government and medical society-run institutions in Gujarat. According to the TOI report, the central government has given nod to a major expansion of PG medical seats across India, adding over 11,000 seats in government and self-financed medical colleges. Regarding the additional PG seats in […]

Medanta signs MoU with the Korean Association to enhance healthcare services

New Delhi: Medanta – one of India’s leading super-speciality hospitals, ranked the Best Private Hospital in India by Newsweek for six consecutive years, has signed a two-year partnership with The Korean Association in India to extend world-class healthcare services to Korean members of the association residing in India.  The Memorandum of Understanding (MoU) was formalized […]

Pharmacist Falls Prey To Rs 1.75 Crore Land Investment Fraud in Gujarat

Ahmedabad: In a shocking betrayal of trust, a Gandhinagar-based man has allegedly cheated a pharmacist of over Rs 1.75 crore under the pretext of a high-return land investment deal. The accused, Bhavik Sureshbhai Raval, reportedly used his long-standing friendship with the victim to gain confidence and persuaded him to transfer property and invest large sums […]

Pharma Firm Gets HC Relief in Rs 64 Lakh NPPA Overpricing Row Over DOLOCIDE-MR

New Delhi: In a long-standing dispute over the pricing control of non-scheduled drugs, the Delhi High Court has granted interim relief to Kee Pharma Limited, manufacturer of DOLOCIDE-MR tablets (Diclofenac 50mg + Paracetamol 325mg + Chlorzoxazone 250mg), restraining the National Pharmaceutical Pricing Authority (NPPA) from taking any coercive steps against the company pursuant to a […]

GSK Shingrix gets nod in China for adults aged 18 years and over with shingles

GSK plc has announced that the China National Medical Products Administration (NMPA) has approved Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) in adults aged 18 years and over who are at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy. Shingles poses a […]